Medicine Prices in Asia–Pacific Countries

Zaheer-Ud-Din Babar; Rabia Hussain; Syed Shahzad Hasan

doi:10.1016/B978-0-12-813166-4.00005-X

Medicine Prices in Asia–Pacific Countries

Zaheer-Ud-Din Babar, Rabia Hussain, Syed Shahzad Hasan

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

4 Citations (Scopus)

Abstract

The chapter summarizes the studies that evaluated medicine prices in Asia–Pacific countries. The primary aim of this review was to report medicine prices in Asia–Pacific region in the last decade and document their significant findings. Almost all included studies have employed World Health Organization/Health Action International methodology to report medicine prices data. The included studies focused on the prices of cancer medicines, central nervous system–related disorders, hepatitis C, and essential medicines for chronic conditions. Affordability is particularly reviewed with medicine prices with a focus on generic medicines for cost savings. Finally, the challenges in formulating medicine pricing policy in Asia–Pacific region are discussed.

Original language	English
Title of host publication	Medicine Price Surveys, Analyses and Comparisons
Subtitle of host publication	Evidence and Methodology Guidance
Editors	Sabine Vogler
Publisher	Elsevier
Chapter	2.3
Pages	45-60
Number of pages	16
Edition	1st
ISBN (Electronic)	9780128132128
ISBN (Print)	9780128131664
DOIs	https://doi.org/10.1016/B978-0-12-813166-4.00005-X
Publication status	Published - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/B978-0-12-813166-4.00005-XLicence: Unspecified

Cite this

@inbook{1429b5bb621b4844beda59bffe3c681f,

title = "Medicine Prices in Asia–Pacific Countries",

abstract = "The chapter summarizes the studies that evaluated medicine prices in Asia–Pacific countries. The primary aim of this review was to report medicine prices in Asia–Pacific region in the last decade and document their significant findings. Almost all included studies have employed World Health Organization/Health Action International methodology to report medicine prices data. The included studies focused on the prices of cancer medicines, central nervous system–related disorders, hepatitis C, and essential medicines for chronic conditions. Affordability is particularly reviewed with medicine prices with a focus on generic medicines for cost savings. Finally, the challenges in formulating medicine pricing policy in Asia–Pacific region are discussed.",

keywords = "Asia–Pacific, High-cost medicines, Prices, Generic medicines, Cancer, CNS",

author = "Zaheer-Ud-Din Babar and Rabia Hussain and Hasan, {Syed Shahzad}",

year = "2019",

doi = "10.1016/B978-0-12-813166-4.00005-X",

language = "English",

isbn = "9780128131664",

pages = "45--60",

editor = "Sabine Vogler",

booktitle = "Medicine Price Surveys, Analyses and Comparisons",

publisher = "Elsevier",

address = "Netherlands",

edition = "1st",

}

TY - CHAP

T1 - Medicine Prices in Asia–Pacific Countries

AU - Babar, Zaheer-Ud-Din

AU - Hussain, Rabia

AU - Hasan, Syed Shahzad

PY - 2019

Y1 - 2019

N2 - The chapter summarizes the studies that evaluated medicine prices in Asia–Pacific countries. The primary aim of this review was to report medicine prices in Asia–Pacific region in the last decade and document their significant findings. Almost all included studies have employed World Health Organization/Health Action International methodology to report medicine prices data. The included studies focused on the prices of cancer medicines, central nervous system–related disorders, hepatitis C, and essential medicines for chronic conditions. Affordability is particularly reviewed with medicine prices with a focus on generic medicines for cost savings. Finally, the challenges in formulating medicine pricing policy in Asia–Pacific region are discussed.

AB - The chapter summarizes the studies that evaluated medicine prices in Asia–Pacific countries. The primary aim of this review was to report medicine prices in Asia–Pacific region in the last decade and document their significant findings. Almost all included studies have employed World Health Organization/Health Action International methodology to report medicine prices data. The included studies focused on the prices of cancer medicines, central nervous system–related disorders, hepatitis C, and essential medicines for chronic conditions. Affordability is particularly reviewed with medicine prices with a focus on generic medicines for cost savings. Finally, the challenges in formulating medicine pricing policy in Asia–Pacific region are discussed.

KW - Asia–Pacific

KW - High-cost medicines

KW - Prices

KW - Generic medicines

KW - Cancer

KW - CNS

UR - https://www.elsevier.com/books/medicine-price-surveys-analyses-and-comparisons/vogler/978-0-12-813166-4

UR - http://www.scopus.com/inward/record.url?scp=85092675433&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-813166-4.00005-X

DO - 10.1016/B978-0-12-813166-4.00005-X

M3 - Chapter

SN - 9780128131664

SP - 45

EP - 60

BT - Medicine Price Surveys, Analyses and Comparisons

A2 - Vogler, Sabine

PB - Elsevier

ER -

Medicine Prices in Asia–Pacific Countries

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this